What Is GPC?
Giant papillary conjunctivitis (GPC) is a chronic inflammatory condition of the upper tarsal conjunctiva (the inner surface of the upper eyelid) characterized by the formation of large papillae greater than 1 mm in diameter. It is one of the most common chronic complications of contact lens wear, though it can also occur with ocular prostheses, exposed sutures, and other foreign bodies.
GPC develops through the combined effects of mechanical irritation and immunological hypersensitivity, making it both a friction-driven and immune-mediated condition.
Causes
Two interacting mechanisms drive GPC development in contact lens wearers:
Mechanical Irritation
- The edge of the contact lens rubs against the upper tarsal conjunctiva with each blink
- Deposits on the lens surface create an irregular, roughened texture that increases friction
- Poor lens edge design or excessive lens movement amplifies the mechanical component
Immunological Response
- Protein deposits (particularly denatured lysozyme) on the lens surface act as antigens
- The immune system mounts a Type I (IgE-mediated) and Type IV (delayed) hypersensitivity response
- Mast cell degranulation releases histamine and other inflammatory mediators
- Chronic inflammation leads to conjunctival tissue remodeling and papillae formation
GPC is not purely mechanical or purely allergic. Both factors contribute simultaneously. This is why management must address both the mechanical stimulus (lens design, edge quality) and the immunological trigger (deposits, lens replacement frequency).
Clinical Signs and Symptoms
Symptoms
- Itching: The hallmark symptom, often worse after lens removal
- Mucous discharge: Stringy, white mucus, especially upon waking
- Decreased lens tolerance: Progressively shorter comfortable wearing times
- Lens decentration: The lens rides up or moves excessively as papillae interfere with lens positioning
- Blurred vision: From mucus coating the lens or lens displacement
Signs
- Papillae on the upper tarsal conjunctiva: Giant papillae (>1 mm) are the defining feature. Evert the upper lid to examine
- Conjunctival hyperemia: Redness of the tarsal conjunctiva
- Mucous strands: Visible between papillae
- Lens coating: Heavy protein and mucous deposits on the lens surface
Staging
GPC progresses through recognizable stages:
| Stage | Papillae Size | Symptoms | Lens Wear |
|---|---|---|---|
| Early | Small, uniform papillae | Mild itching, slight mucus | Usually tolerable |
| Moderate | Enlarged papillae (0.5-1 mm) | Increasing itching and discharge | Reduced comfort |
| Advanced | Giant papillae (>1 mm) | Significant itching, heavy mucus | Lens intolerance common |
| Severe | Giant papillae with apical flattening | Cannot tolerate lenses | Lens wear discontinued |
Management
Management depends on the stage of GPC and addresses both the mechanical and immunological components:
Lens Modifications
- Switch to daily disposable lenses: Eliminates deposit accumulation entirely and is often the most effective single intervention
- Increase replacement frequency: If daily disposables are not feasible, shorten the replacement cycle (monthly to two-week, for example)
- Change lens material: Non-ionic, low-water-content materials accumulate less protein
- Change lens edge design: A thinner, smoother edge reduces mechanical irritation
- Consider GP lenses: Smaller diameter and deposit-resistant surface can resolve GPC in some cases
Temporary Discontinuation
- Moderate to severe cases may require 2-4 weeks without lens wear to allow inflammation to resolve
- Papillae may take months to fully flatten even after symptoms resolve
Pharmacological Support
- Mast cell stabilizers (cromolyn sodium, lodoxamide): Prevent mast cell degranulation and reduce the immune component
- Topical antihistamines: Provide symptomatic relief from itching
- Combination agents (olopatadine, ketotifen): Offer both mast cell stabilization and antihistamine activity
Attempting to manage GPC solely with medication while continuing the same lens and replacement schedule. Pharmacological treatment addresses symptoms and inflammation, but without removing the mechanical and antigenic stimulus (deposits, lens edge irritation), the condition will persist or recur.
Always evert the upper lid during contact lens follow-up exams. Early GPC can be detected before the patient reports significant symptoms, allowing intervention before the condition progresses to lens intolerance.
Key Takeaways
- GPC is characterized by giant papillae (>1 mm) on the upper tarsal conjunctiva
- Caused by the combination of mechanical irritation (lens edge, deposits) and immunological hypersensitivity (denatured proteins)
- Cardinal symptom is itching, especially after lens removal
- Daily disposable lenses are often the most effective management strategy
- Pharmacological treatment (mast cell stabilizers, antihistamines) supports but does not replace lens modifications
- Always evert the upper lid at follow-up exams to detect early GPC